Stay updated on GABA-A Targeting in ASD Clinical Trial
Sign up to get notified when there's something new on the GABA-A Targeting in ASD Clinical Trial page.

Latest updates to the GABA-A Targeting in ASD Clinical Trial page
- ChecktodayChange DetectedThe site footer revision label changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe ClinicalTrials.gov record for the completed FAST-AS study is displayed, describing a Phase 2 trial of AZD7325 versus placebo for adults with autism spectrum disorder. It also provides study eligibility, participating locations, outcomes, and record history.SummaryDifference39%

- Check21 days agoChange DetectedThe 403 Forbidden message is gone, and the page shows the ClinicalTrials.gov site shell without visible study details.SummaryDifference0.6%

- Check28 days agoChange DetectedA banner announces the NIH website transition and says that some content may use “Super Intelligence” instead of “Artificial Intelligence.”SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the study record remains behind a 403 error page.SummaryDifference0.2%

- Check42 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

Stay in the know with updates to GABA-A Targeting in ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GABA-A Targeting in ASD Clinical Trial page.